Harmony Biosciences Holdings, Inc.
A biopharmaceutical company in Plymouth Meeting, Pennsylvania, that makes WAKIX (pitolisant), a medication for narcolepsy that helps people with the sleep disorder stay awake and controls sudden muscle weakness (cataplexy). Founded in 2017 by Paragon Biosciences, the company licensed the drug's U.S. rights from the French firm Bioprojet. The brand name WAKIX is a play on the word "wake," and unlike many narcolepsy treatments, it is not a controlled substance.
Granted 23.6K
Granted 73.5K · Sold 48.1K
Granted 43.5K · Sold 25.9K
Granted 7.5K
Granted 5.1K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Budur KumarCHIEF MEDICAL OFFICER · 6 transactions | +76% | 33.0K | 23.6K | — | — |
| Kapadia SandipCHIEF FINANCIAL OFFICER · 11 transactions | — | 24.5K | 73.5K | — | 48.1K |
| Dayno Jeffrey M.PRESIDENT, CEO, Director · 7 transactions | +23.8% | 13.0K | 43.5K | — | 25.9K |
| Zaeske Adam H.CHIEF COMMERCIAL OFFICER · 2 transactions | — | 4.3K | 7.5K | — | — |
| Serafin AndrewCHIEF STRATEGY OFFICER · 4 transactions | -9.8% | 1.5K | 5.1K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last year: -74.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.